IOBT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Io Biotech Inc (IOBT).


$60.61M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

IOBT Market Cap. (MRY)


IOBT Shares Outstanding (MRY)


IOBT Assets (MRY)


Total Assets

$67.70M

Total Liabilities

$20.68M

Total Investments

$268.00K

IOBT Income (MRY)


Revenue

$0

Net Income

-$95.49M

Operating Expense

$95.18M

IOBT Cash Flow (MRY)


CF Operations

-$82.35M

CF Investing

-$44.00K

CF Financing

$0

IOBT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

IOBT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$67,699,000 (-55.08%)

$150,718,000 (-0.72%)

$151,805,000 (-31.71%)

$222,288,000 (3832.21%)

Assets Current

$64,951,000 (-55.89%)

$147,255,000 (-0.65%)

$148,219,000 (-33.16%)

$221,738,000 (3835.01%)

Assets Non-Current

$2,748,000 (-20.65%)

$3,463,000 (-3.43%)

$3,586,000 (552.00%)

$550,000 (2955.56%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$47,015,000 (-64.69%)

$133,162,000 (-4.10%)

$138,854,000 (-34.48%)

$211,924,000 (700.30%)

Property Plant & Equipment Net

$2,363,000 (-23.92%)

$3,106,000 (-3.96%)

$3,234,000 (1986.45%)

$155,000 (0%)

Cash & Equivalents

$60,031,000 (-58.08%)

$143,193,000 (0.42%)

$142,590,000 (-32.59%)

$211,531,000 (6112.36%)

Accumulated Other Comprehensive Income

-$6,851,000 (29.14%)

-$9,669,000 (4.65%)

-$10,141,000 (-581.06%)

-$1,489,000 (-175.93%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$268,000 (0.00%)

$268,000 (0.00%)

$268,000 (0.00%)

$268,000 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$268,000 (0.00%)

$268,000 (0.00%)

$268,000 (0.00%)

$268,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,661,000 (20.19%)

$3,878,000 (-3.15%)

$4,004,000 (1.93%)

$3,928,000 (652.49%)

Accumulated Retained Earnings (Deficit)

-$359,313,000 (-36.20%)

-$263,822,000 (-48.43%)

-$177,739,000 (-67.23%)

-$106,281,000 (-176.76%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,915,000 (-23.22%)

$2,494,000 (-10.61%)

$2,790,000 (0%)

$0 (0%)

Debt Current

$717,000 (9.47%)

$655,000 (27.18%)

$515,000 (0%)

$0 (0%)

Debt Non-Current

$1,198,000 (-34.86%)

$1,839,000 (-19.16%)

$2,275,000 (0%)

$0 (0%)

Total Liabilities

$20,684,000 (17.82%)

$17,556,000 (35.56%)

$12,951,000 (24.96%)

$10,364,000 (239.80%)

Liabilities Current

$19,486,000 (23.98%)

$15,717,000 (47.22%)

$10,676,000 (3.60%)

$10,305,000 (237.87%)

Liabilities Non-Current

$1,198,000 (-34.86%)

$1,839,000 (-19.16%)

$2,275,000 (3755.93%)

$59,000 (0%)

IOBT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$23,693,000 (0.33%)

$23,614,000 (-3.37%)

$24,438,000 (120.52%)

$11,082,000 (559.25%)

Research & Development Expense

$71,484,000 (5.39%)

$67,829,000 (44.36%)

$46,986,000 (55.83%)

$30,152,000 (256.24%)

Operating Expenses

$95,177,000 (4.08%)

$91,443,000 (28.03%)

$71,424,000 (73.22%)

$41,234,000 (306.45%)

Interest Expense

$0 (0%)

$0 (0%)

$302,000 (-16.34%)

$361,000 (1288.46%)

Income Tax Expense

$1,443,000 (69.37%)

$852,000 (-33.07%)

$1,273,000 (1772.06%)

$68,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$95,491,000 (-10.93%)

-$86,083,000 (-20.47%)

-$71,458,000 (-5.27%)

-$67,879,000 (-463.69%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$95,491,000 (-10.93%)

-$86,083,000 (-20.47%)

-$71,458,000 (-5.27%)

-$67,879,000 (-463.69%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$7,108,000 (178.53%)

Net Income Common Stock

-$95,491,000 (-10.93%)

-$86,083,000 (-20.47%)

-$71,458,000 (4.71%)

-$74,987,000 (-413.82%)

Weighted Average Shares

$65,880,914 (51.31%)

$43,539,976 (51.10%)

$28,815,267 (564.62%)

$4,335,629 (2346.74%)

Weighted Average Shares Diluted

$65,880,914 (51.31%)

$43,539,976 (51.10%)

$28,815,267 (564.62%)

$4,335,629 (2346.74%)

Earning Before Interest & Taxes (EBIT)

-$94,048,000 (-10.34%)

-$85,231,000 (-21.96%)

-$69,883,000 (-3.61%)

-$67,450,000 (-461.33%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$95,177,000 (-4.08%)

-$91,443,000 (-28.03%)

-$71,424,000 (-73.22%)

-$41,234,000 (-306.45%)

IOBT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$44,000 (86.38%)

-$323,000 (53.19%)

-$690,000 (-350.98%)

-$153,000 (0%)

Net Cash Flow from Financing

$0 (0%)

$71,860,000 (0%)

$0 (0%)

$252,951,000 (4857.88%)

Net Cash Flow from Operations

-$82,347,000 (-14.79%)

-$71,737,000 (-20.10%)

-$59,729,000 (-46.95%)

-$40,646,000 (-308.26%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$82,391,000 (-41095.50%)

-$200,000 (99.67%)

-$60,419,000 (-128.48%)

$212,152,000 (4470.66%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$44,000 (86.38%)

-$323,000 (53.19%)

-$690,000 (-350.98%)

-$153,000 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$71,860,000 (0%)

$0 (0%)

$103,350,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$771,000 (-196.01%)

$803,000 (109.42%)

-$8,522,000 (-126.77%)

-$3,758,000 (-1009.93%)

Share Based Compensation

$6,526,000 (-19.02%)

$8,059,000 (14.47%)

$7,040,000 (293.08%)

$1,791,000 (2698.44%)

Depreciation Amortization & Accretion

$849,000 (12.30%)

$756,000 (40.00%)

$540,000 (26900.00%)

$2,000 (0%)

IOBT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-115.30% (-73.91%)

-66.30% (-52.76%)

-43.40% (48.88%)

-84.90% (-271.17%)

Return on Average Assets (ROAA)

-96.10% (-61.24%)

-59.60% (-45.72%)

-40.90% (37.84%)

-65.80% (66.01%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

2769.80% (-27.85%)

3838.80% (437.54%)

-1137.30% (-102.95%)

38542.90% (2151.73%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.63 (33.19%)

-0.95 (-2.37%)

-0.93 (-150.54%)

-0.37

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.29 (38.60%)

0.93 (94.97%)

0.48 (-45.17%)

0.87

Debt to Equity Ratio (D/E)

0.44 (233.33%)

0.13 (41.94%)

0.09 (89.80%)

0.05 (156.98%)

Earnings Per Share (EPS)

-1.45 (26.77%)

-1.98 (20.16%)

-2.48 (85.66%)

-17.3 (78.99%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.25 (24.41%)

-1.66 (21.08%)

-2.1 (77.72%)

-9.41 (83.25%)

Book Value Per Share (BVPS)

0.71 (-76.65%)

3.06 (-36.54%)

4.82 (-90.14%)

48.88 (124.53%)

Tangible Assets Book Value Per Share (TABVPS)

1.03 (-70.31%)

3.46 (-34.28%)

5.27 (-89.72%)

51.27 (60.71%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

1 (150.00%)

-2

Enterprise Value Over EBITDA (EV/EBITDA)

0.19 (-59.31%)

0.46 (-61.08%)

1.19 (157.62%)

-2.06

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.33 (-64.43%)

9.37 (-32.51%)

13.88 (-35.48%)

21.52 (1064.39%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$82,391,000 (-14.34%)

-$72,060,000 (-19.27%)

-$60,419,000 (-48.09%)

-$40,799,000 (-309.79%)

Enterprise Value (EV)

-$17,555,559 (55.03%)

-$39,041,882 (52.57%)

-$82,321,886 (-159.25%)

$138,940,709

Earnings Before Tax (EBT)

-$94,048,000 (-10.34%)

-$85,231,000 (-21.44%)

-$70,185,000 (-3.50%)

-$67,811,000 (-463.12%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$93,199,000 (-10.33%)

-$84,475,000 (-21.82%)

-$69,343,000 (-2.81%)

-$67,448,000 (-461.32%)

Invested Capital

-$9,903,000 (-73.80%)

-$5,698,000 (-528.74%)

$1,329,000 (194.03%)

$452,000 (156.36%)

Working Capital

$45,465,000 (-65.44%)

$131,538,000 (-4.37%)

$137,543,000 (-34.95%)

$211,433,000 (8079.23%)

Tangible Asset Value

$67,699,000 (-55.08%)

$150,718,000 (-0.72%)

$151,805,000 (-31.71%)

$222,288,000 (3832.21%)

Market Capitalization

$60,610,441 (-51.06%)

$123,856,118 (86.88%)

$66,275,114 (-64.06%)

$184,417,709

Average Equity

$82,829,500 (-36.22%)

$129,872,250 (-21.08%)

$164,553,250 (86.33%)

$88,310,500 (400.20%)

Average Assets

$99,317,500 (-31.23%)

$144,417,500 (-17.33%)

$174,694,500 (53.28%)

$113,970,500 (1411.95%)

Invested Capital Average

-$3,395,500 (-52.93%)

-$2,220,250 (-136.13%)

$6,144,500 (3611.14%)

-$175,000 (75.07%)

Shares

65,880,914 (0.00%)

65,880,914 (128.63%)

28,815,267 (0.00%)

28,815,267 (12.00%)